(Oxydi-2,1-phenylene)bis(diphenylphosphine)

We are (Oxydi-2,1-phenylene)bis(diphenylphosphine) CAS:166330-10-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  (Oxydi-2,1-phenylene)bis(diphenylphosphine)
CAS.NO:166330-10-5
Molecular Formula:C36H28OP2
Molecular Weight:538.55400

Synonyms:
Bis[2-(diphenylphosphino)phenyl] Ether
Bis(2-diphenylphosphinophenyl)ether
(Oxybis(2,1-phenylene))bis(diphenylphosphine)
2,2'-Bis(diphenylphosphino)diphenyl Ether
Bis[(2-diphenylphosphino)phenyl] ether
[2-(2-diphenylphosphanylphenoxy)phenyl]-diphenylphosphane

Physical and Chemical Properties:
Density: /
Boiling point: 608.19ºC at 760 mmHg
Melting point: 184-187 °C(lit.)
Flash point: 404.905ºC
Refractive index: /

Specification:
Appearance:White Powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

 (Oxydi-2,1-phenylene)bis(diphenylphosphine)


Related News: Such was the apparent demand sparked by the notice that the compound formula sold out on some stores on China’s e-commerce platform Taobao.1,3-difluorobenceno CAS:372-18-9 Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.6-methyl-5-nitropyridin-2-amine This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.4-(Methylsulfonyl)phenylboronic Acid CAS:149104-88-1 In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.

Related Products
Product Name
2-Chloro-4-picoline View Details
1-(3-bromophenyl)ethanone Cas:2142-63-4 View Details
N-acetyl-4-oxo-L-proline View Details
Pentapeptide-3 manufacturer 2-Hydroxy-5-trifluoromethylpyridine manufacturer N4-Isobutylquinoline-3,4-diamine manufacturer 2,2,3,3,3-Pentafluoropropan-1-amine manufacturer 4-Methyl-1,3′-Cyclohexanediamine(HTDA) manufacturer